Benedikt SchwarzeDr. rer. nat.
CEO, Strategy Lead and Fundraising
Biotechnology • Leipzig, Germany
insiliCAR
AI-driven cell therapeutics against solid tumors
Solid tumors present complex immunosuppressive microenvironments and high off-tumor toxicity risks. At insiliCAR, we combine AI-driven de novo protein design and synthetic biology to engineer modular, curative cell therapeutics designed specifically to conquer solid tumors.
Leadership & Science
The Team
Six multidisciplinary scientists and operators bridging artificial intelligence, structural biology, pharmacy, and oncology in Leipzig and Regensburg.
Franz DietzmeyerDipl.-Pharm.
Head of Partnerships and Operations
Vivian HaasM.Sc. Biochem.
Head of Science and CAR Expert
Tom U. SchlegelDipl.-Pharm.
Head of Brand and Marketing
Paul SchebekM.Sc. Chem.
Head of Technology and Protein Design
Markus BardenDr. med.
Head of Clinical Development and Trial Design
Updates & Engagements
News & Events
Milestones and upcoming conference appearances where you can connect with the insiliCAR team.
Meet Us In Person
14. Start-up Days 2026 (Leibniz-Gemeinschaft)
30. September – 01. Oktober 2026 • Berlin, Germany
Our founding team will be attending the 14th Leibniz Start-up Days at Spielfeld Digital Hub in Berlin, joining researchers and founders from Leibniz, Max Planck, Helmholtz, and Fraunhofer to discuss breakthrough scientific spin-offs.
Incubator Batch 2
BoOst Startup Factory
Saxony, Germany • Incubator Batch 2
insiliCAR has been selected for Batch 2 of the BoOst Startup Factory incubator program. Backed by Saxony’s premier startup initiative, BoOst supports our development from university spin-off to scalable cell therapy venture.
Location
Leipzig, Germany
51.3397° N, 12.3731° E • Saxony, Germany